Membrane bioreactors (MBRs) exhibit highly variable removal efficiencies for pharmaceutical metabolites and organic micropollutants, even under similar operating conditions. Diclofenac and carbamazepine, for instance, show elimination rates that differ markedly across installations and studies. The membrane’s separation parameters—pore size, diameter, or structure—and the chemical nature of its material do not fully explain these differences. Instead, processes at the sludge–membrane interface, particularly sorption and biofilm-related interactions, appear to dominate. Recent studies indicate that MBR performance depends largely on events at the membrane surface: microbial adhesion mechanisms, biofilm development, and community organization. Better pollutant removal stems from prolonged contact with the biofilm and transformation within this layer, not from mechanical filtration alone. Here, we examine membrane surface modification strategies using biopolymers (cellulose, chitosan, and alginate) and their effects on membrane–biofilm interactions. Research suggests that effective biopolymer coatings for MBRs must stabilize the hydration layer, maintain near-neutral surface charge, show moderate cross-linking density for durability and flexibility, and create controlled nanotopography that favors porous, active biofilms over compact sludge layers. This understanding supports the development of durable, low-energy MBR membranes with improved stability and more predictable micropollutant removal in real-world applications.
Kudzin et al. (Fri,) studied this question.